Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study (Q58897912)

From Wikidata
Jump to navigation Jump to search
scientific article published on 04 May 2007
edit
Language Label Description Also known as
English
Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study
scientific article published on 04 May 2007

    Statements

    Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit